RE: Positive RNS soon...4 Jan 2024 09:44
Nah. Deeper into the mire with RF. market knows full well RF has GDR on the floor with its boot firmly on the company’s neck. Cheek is imv unsurprisingly able to do much about it. Budd stayed just long enough to make sure irreparable damage was done with this deal.
If Cheek can save GDR either from administration or a distressed sale then he’ll deserve double what Budd made in terms of salary. Odds not looking too good just at the minute. We’ve had two lots of the possible good news Cheek spoke about in the recent presentation. Just a single NHS hospital has adopted AIHL and sales to several countries just to help generate data, get the product registered and recognised and ultimately on the shelves.
This leaves FDA news. What ever happens on this front yet another raise is going to be needed - and we were told this categorically by Cheek himself. Just my take but there’s a big dollop of dilution on the way and, whilst painful in the short term, it should finally put GDR back on track and at the races by end of 2024.
It’s long patient hold and for me a case of topping up as and when the sp drops to 7p or below. One day this stock is going to make me shed loads of money. Just not yet.